A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Review of Low-Dose CT Lung Cancer Screenings in a Community-Based Healthcare System With High Incidence
- Status
- COMPLETED
- Phase
- N/A
Clinical Trial to Evaluate the Safety and Effects of Ethnicity and Food on Pharmacokinetics of YH25448
- Status
- COMPLETED
- Phase
- PHASE1
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Epidermal Growth Factor Receptor (EGFR) T790M Mutation Testing Practices in Hong Kong
- Status
- WITHDRAWN
- Phase
- N/A
A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Circulating Tumor DNA Exposure in Peripheral Blood
- Status
- UNKNOWN
- Phase
- N/A
Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)
- Status
- COMPLETED
- Phase
- PHASE3
REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Investigate the Food Effect on the Pharmacokinetics of Ensartinib Capsules in Chinese Healthy Volunteers.
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
BT1718 in Patients with Advanced Solid Tumours.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Osimertinib in Clinical Practice Among Chinese NSCLC Patients
- Status
- COMPLETED
- Phase
- N/A